Does gluten exposure trigger zonulin release that increases intestinal permeability in celiac disease?

Mechanistic pathways

Scientific evidence establishes a clear, multi-step cellular pathway linking gluten exposure to increased intestinal permeability in celiac disease:

• Innate signaling cascade: Upon gluten exposure, specific immunogenic gliadin peptides (such as the p31-43 fragment) bind directly to the CXCR3 chemokine receptor on the surface of intestinal epithelial cells.
• Zonulin secretion: This CXCR3 receptor engagement initiates an intracellular, MyD88-dependent signaling cascade that triggers the luminal secretion of zonulin, an endogenous modulator of intercellular tight junctions.
• Receptor activation: Once released, zonulin binds to target cell-surface receptors, specifically epidermal growth factor receptor (EGFR) and protease-activated receptor 2 (PAR2).
• Cytoskeletal rearrangement: This binding activates protein kinase C (PKC) and phosphorylates myosin light chain kinase (MLCK), causing actomyosin contraction.
• Tight junction disassembly: The resulting physical tension reorganizes the actin cytoskeleton and displaces key tight junction proteins—such as zonula occludens-1 (ZO-1), occludin, and claudins—from the junctional complex. This opens the paracellular gateway, allowing macromolecular gliadin peptides to cross the epithelial barrier into the lamina propria.

Clinical evidence

• Enhanced mucosal response: Ex vivo duodenal biopsy studies demonstrate that while gliadin can induce zonulin release in healthy tissues, this secretory response is significantly upregulated and prolonged in patients with active celiac disease.
• Reversibility: In celiac patients who successfully adhere to a strict gluten-free diet, mucosal CXCR3 receptor expression and zonulin-mediated permeability responses return toward normal baseline levels.
• Therapeutic validation: The functional role of this pathway is clinically validated by tight junction regulators like larazotide acetate. In clinical trials, this peptide antagonist successfully blocked zonulin-induced tight junction disassembly, reducing macromolecular permeability and improving gluten-induced symptoms.

Bottom line

The scientific consensus strongly supports the claim. In celiac disease, gluten exposure binds to epithelial CXCR3 receptors, triggering a robust, MyD88-dependent release of zonulin. This released zonulin activates EGFR/PAR2 and PKC signaling, which disassembles tight junction proteins and directly increases intestinal permeability.